Earnings Season Scorecard and Analyst Reports for Mastercard, Pfizer & Citigroup
Zacks Investment Research | Jan 25, 2022 12:27AM ET
Tuesday, January 25, 2022
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features a real-time update on the ongoing Q4 earnings season, in addition to new research reports on 12 major stocks, including Mastercard Incorporated (NYSE:MA), Pfizer Inc. (NYSE:PFE), and Citigroup Inc. (NYSE:C). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see click here>>>
Today's Must Read
Mastercard's (MA) Accretive Buyouts Aid, Elevated Costs Hurt
COVID Vaccine & Pill to Drive Pfizer's (PFE) 2022 Sales
Citigroup's (C) Streamlining Efforts Aids Amid Rising Expenses
Featured Reports
Cost Management & Regulated investment Aid Exelon (EXC)
Per the Zacks analyst Exelon's cost management initiatives will have positive impact on margins and its planned $27B investments through 2024 will strengthen its operation.
Kinder Morgan (KMI) to Benefit From Growing Demand for RNG
The Zacks analyst is upbeat about Kinder Morgan's huge growth potential in the RNG business, which will broaden its scope of services. However, its huge exposure to debt is concerning.
CSX Backed by Improved Freight Demand Amid Cost Headwinds
The Zacks analyst is optimistic about CSX's top line growth, thanks to improved freight demand and pricing gains. However, high costs, primarily due to rising fuel expenses are concerning.
Robust Senza Uptake Aids Nevro (NVRO) Amid Stiff Competition
The Zacks analyst is upbeat about continued strength in Nevro's flagship platform, Senza. Yet, the company's operation in a highly competitive medical device industry raises apprehension.
TopBuild (NYSE:BLD) Gains From Buyouts, Supply Woes Persist
The Zacks analyst stresses that TopBuild's systematic inorganic strategy will supplement its organic growth and expand access to additional markets and products. However, supply constraints are risks.
New Upgrades
Inorganic Growth, Reducing Costs Aid Community Heath (CYH)
Per the Zacks analyst, a series of inorganic growth measures such as buyouts have enhanced its capabilities. Moreover, its cost-curbing measures is likely to aid margins going forward.
Customer Demand Drives DICK'S Sporting's (DKS) Top Line
Per the Zacks analyst, DICK'S Sporting is gaining from solid demand and improved product assortment, driving solid sales. Q3 sales grew 13.9% year over year and 40% on a two-year basis.
Get The News You Want
New Downgrades
Cost Inflation Hurts Post Holdings' (NYSE:POST) Margin
Per the Zacks analyst, Post Holdings is grappling with escalated costs. Input and freight inflation along with increased manufacturing costs hurt the company's fourth-quarter margin performance.
Higher Costs & Supply Chain Issues Hurt PPG Industries (NYSE:PPG)
The Zacks analyst is concerned that pandemic-led supply-chain challenges could hurt the company's performance. Higher raw material and logistics costs might also impact its results.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How to Profit from Trillions on Spending for Infrastructure >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.